Unaudited Quarterly Financial Results for Quarter and Half Year Ended on 30th September 2026.

GOLDCOIN HEALTH FOODS LIMITED CIN: L15419GJ1989PLC012041 Address: A/16 1st Floor, Vardan Tower, Pragati Nagar, Gold Coin Naranpura, Ahmedabad -380013 M.: 094267 68644 Email: goldcoinhealth@gmail.com Date: 2ndNovember, 2026 The Manager, Listing BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 SYMBOL: GOLDCOINHF CODE: 538542 Subject: Submission of Unaudited Financial Results for the Second Quarter ended on 30th September, 2026. Dear Sir/Madam, In reference to captioned subject and pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Standalone Unaudited Financial Results for the Second Quarter and Half Year ended on 30t September, 2026. Please take note of the same and oblige. Yours faithfully, FOR GOLDCOIN HEALTH FOODS LIMITED AL a2 DEVANG PRAFULCHANDRA SHAH MANAGING DIRECTOR DIN: 00633868 INDIA & ASSOCIATES CHARTERED ACCOUNTANTS ed Review Report Independent Auditor's Review Report on Quarterly Unaudited Standalone Financial Results of the Company pursuant to Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (as amended) Board of Directors of Goldcoin Health Foods Limited We have reviewed the accompanying statement of unaudited financial results of Goldcoin Health Foods Limited (“the Company”) for the quarter ended 30" September, 2026 (“the statement”), which are included in the accompanying “Statement of Unaudited Financial Result for Quarter ended September 30, 2026” together with relevant notes thereon. The statement has been prepared by company pursuant to regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”). The statement is the responsibility of the company’s management and has been approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Ind AS 34 “Interim Financial Reporting (Ind AS 34), prescribed under section 133 of the companies act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to issue a report on the statement based on our review. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the ICAI. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review of Interim Financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an Audit. Accordingly, we do not express an Audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards (‘Ind AS’) specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. Date :02/11/2026 For, VS S B & Associates Place :Ahmedabad Chartered Accountants Firm No. 121356W wves A. Shah Partner M. No. 109944 UDIN: 26109944BFJYLE1079 HEAD OFFICE: A/912, 9th Floor, Ratnaakar Nine Square, Opp. ITC Narmada Hotel, Vastrapur, Ahmedabad — 380015, GJ (0) 079 2754 1783 (m) +91 93777 71182 (e) cavishves@/ cgasmhraidiharl@g.macilo.cmom GOLDCOIN HEALTH FOODS LIMITED (CIN : L15419GJ1989PLC012041) e-mail: goldcoinkealth@gmail.com Reg, Office: A/16 Ist Floor, Vardan Tower Pragatinagar, Naranpura Vistar, Ahmedabad Ahmadabad City, Gujarat, India, 380013 STATEMENT N ED FINANCIAL RE: UARTER Al NDI 0, 2021 (Rs. In lacs except Per share data) Half Year ended Half Year ended Quarter ended Quarter ended September 30, September 30, For the year ended on srNo Particulars Septe 2m 02b 6e r 30, Q Ju ua nr et e 3r 0 ,e 2n 0d 2e 6d Sept 2e 0m 2b 5e r 30, da2 t0 e2 f6 o r( Y Ce ua rr r eto n t 2025 (Year to date| March 31,2026 for Previous Period) Period) Un-Audited Un-Audited Un-Audited Un-Audited Un-Audited Audited Revenue From Operations (a) Revenue from Operations 213 182 214 395 9.07 (b) Other Income 032 030 0.32 15.82 Total Income (Net) 2.45 1.82 2.44 427 16.69 24.89 Expenses a. Cost of Materials Consumed b. Purchases of Stock-in-trade 160 182 340 351 777 c_Changes in inventories of Stockin-Trade d_ Employee benefits expenses 2.25 2.60 450 485 970 e Finance Cost 027 023 030 034 083 T.Depreciation and Amortization Expenses 001 0.01 0.03 0.03 0.06 g Other Expenses 652 021 751 529 11.05 ‘Total Expenses 10.65 4.87 15.73 14.03 2941 Profit/ (Loss) before Exceptional and Extraordinary (84 (244) (11.47) 2.66 (.52) items and tax (1-2) Exceptional ltems Profit/ (Loss) before Extraordinary items and tax (3-4) (884) (244) (11.47) 266 (452) Extraordinary Items Profit Before Tax (5-6) (884) (2.44) (1L147) 266 (452) ‘Tax Expenses (a) Current Tax (1.60) (b) Deferred Tax Total Tax Expenses (1.60) Net Profiti(Loss) for the period from continuing Operations (0.83)| (7-8) 10 Profit (Loss) from Discontinuing operations before Tax “Tax Expenses ofD iscontinuing Operations 2 Net Profit(Loss) from Discontinuing operations after Tax (10- Share of Profit (Loss) ofa ssociates and Joint Ventures accounted for using equity method Net Profit (Loss) for the period (9+12+13) 2.66 (452) Other comprehensive income, net of income tax @)1) Amount of item that will not be reclassified to profitor loss i) Income tax relating to items that will ot be reclassificd to profit or loss b) i) item that will be reclassified to profit o loss i) income tax relating ( it s that will be reclassified (© profit lor loss Total other comprehensive income, net of income tax (11.47) 2.66 (4.52) Total Comprehensive income for the period Details of equity share capital Paid-up Equity Share Capital 150,05 150,05 15005 300.09 150,05 Face Value of Equity Share_Capital 10.00 10.00 10.00 10.00 10.00 Details of debt securities Paid -Up Debt capital Face value ofd ebt Securities Reserve excluding revaluation reserves as per balance . (52.79) sheet of previous accounting year 20 Debenture Redemption reserve 21 Earning per Share Earning per Share for Continuing Operations Basic Eamning (Loss) per share from Continuing operations (0.18) (0.59)] (0.03) (0.76) 0.09 (030) Diluted Eaming (Loss) per share from Continuing (0.18) (059) (0.03) (0.76)| 009 (0.30)] operations Earning per Share for discontinving Operations Basic Eaming (Loss) per share from discontinuing operations Diluted Eaming (Loss) per share from discontinuing operations Earnings per Equity Share Basic Eaming (Loss) per share from Continuing and (©.18) (0.03) (0.76)} | discontinuing operations Diluted Eaming (Loss) per share from Continuing and (0.13) (0.03) (0.76) discontinuing operations The above un-audited financial results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on 2nd November, 2026. [The previous periods figures have been regrouped wherever necessary. During the previous year, the Company implemented a scheme of reduction of sharc capital followed by consolidation of equity shares, whereby equity shares of face v [Showing first 8,000 characters — download PDF for full document]